26.03.2014 • NewsBayerDede Willamscoatings and adhesives

Bayer Breaks Ground for New HDI Plant at Shanghai

Bayer MaterialScience (BMS) has broken ground on a new 50,000 t/y plant for coatings and adhesives precursor hexamethylene diisocyanate (HDI) at its complex in Shanghai, China.

The plant due for start-up in 2016, is being touted as one of the largest facilities of its kind in the world. Bayer already has one HDI plant in Shanghai, which was expanded in 2013 from its original annual capacity of 30,000 t/y.

Tony Van Osselaer, head of industrial operations at BMS, said locating the new plant at the integrated Shanghai site will allow the company to introduce a new manufacturing process that has a low environmental impact while also satisfying stringent safety requirements. The gas-phase technology requires substantially less energy and solvent than conventional processes, he said.

"The construction of our new HDI plant documents our confidence in the Asia/Pacific market and China, in particular," said Daniel Meyer, who heads the Coatings, Adhesives, Specialties (CAS) business unit.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.